Literature DB >> 29536636

Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.

Jingjie Ge1, Jianjun Wu2, Shichun Peng3, Ping Wu1, Jian Wang2, Huiwei Zhang1, Yihui Guan1, David Eidelberg3, Chuantao Zuo1, Yilong Ma3.   

Abstract

Progressive supranuclear palsy (PSP) is a rare movement disorder and often difficult to distinguish clinically from Parkinson's disease (PD) and multiple system atrophy (MSA) in early phases. In this study, we report reproducible disease-related topographies of brain network and regional glucose metabolism associated with PSP in clinically-confirmed independent cohorts of PSP, MSA, and PD patients and healthy controls in the USA and China. Using 18 F-FDG PET images from PSP and healthy subjects, we applied spatial covariance analysis with bootstrapping to identify a PSP-related pattern (PSPRP) and estimate its reliability, and evaluated the ability of network scores for differential diagnosis. We also detected regional metabolic differences using statistical parametric mapping analysis. We produced a highly reliable PSPRP characterized by relative metabolic decreases in the middle prefrontal cortex/cingulate, ventrolateral prefrontal cortex, striatum, thalamus and midbrain, covarying with relative metabolic increases in the hippocampus, insula and parieto-temporal regions. PSPRP network scores correlated positively with PSP duration and accurately discriminated between healthy, PSP, MSA and PD groups in two separate cohorts of parkinsonian patients at both early and advanced stages. Moreover, PSP patients shared many overlapping areas with abnormal metabolism in the same cortical and subcortical regions as in the PSPRP. With rigorous cross-validation, this study demonstrated highly comparable and reproducible PSP-related metabolic topographies at network and regional levels across different patient populations and PET scanners. Metabolic brain network activity may serve as a reliable and objective marker of PSP, although cross-validation applying recent diagnostic criteria and classification is warranted.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  PET; differential diagnosis; disease-related brain network markers; movement disorders; multivariate and univariate brain mapping methods; parkinsonism

Mesh:

Substances:

Year:  2018        PMID: 29536636      PMCID: PMC6033655          DOI: 10.1002/hbm.24044

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  50 in total

1.  Brain perfusion differences in parkinsonian disorders.

Authors:  Noriyuki Kimura; Syojirou Hanaki; Teruaki Masuda; Takuya Hanaoka; Yusuke Hazama; Toshio Okazaki; Ryuki Arakawa; Toshihide Kumamoto
Journal:  Mov Disord       Date:  2011-08-09       Impact factor: 10.338

2.  Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.

Authors:  Yilong Ma; Chengke Tang; Phoebe G Spetsieris; Vijay Dhawan; David Eidelberg
Journal:  J Cereb Blood Flow Metab       Date:  2006-06-28       Impact factor: 6.200

3.  Network modulation in the treatment of Parkinson's disease.

Authors:  Kotaro Asanuma; Chengke Tang; Yilong Ma; Vijay Dhawan; Paul Mattis; Christine Edwards; Michael G Kaplitt; Andrew Feigin; David Eidelberg
Journal:  Brain       Date:  2006-07-14       Impact factor: 13.501

4.  The representation of blinking movement in cingulate motor areas: a functional magnetic resonance imaging study.

Authors:  Takashi Hanakawa; Michael A Dimyan; Mark Hallett
Journal:  Cereb Cortex       Date:  2007-07-25       Impact factor: 5.357

5.  Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder.

Authors:  Ping Wu; Huan Yu; Shichun Peng; Yves Dauvilliers; Jian Wang; Jingjie Ge; Huiwei Zhang; David Eidelberg; Yilong Ma; Chuantao Zuo
Journal:  Brain       Date:  2014-10-22       Impact factor: 13.501

Review 6.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

7.  Validation of parkinsonian disease-related metabolic brain patterns.

Authors:  Laura K Teune; Remco J Renken; Deborah Mudali; Bauke M De Jong; Rudi A Dierckx; Jos B T M Roerdink; Klaus L Leenders
Journal:  Mov Disord       Date:  2013-03-11       Impact factor: 10.338

8.  Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners.

Authors:  Shichun Peng; Yilong Ma; Phoebe G Spetsieris; Paul Mattis; Andrew Feigin; Vijay Dhawan; David Eidelberg
Journal:  Hum Brain Mapp       Date:  2013-05-14       Impact factor: 5.038

9.  Loss of pedunculopontine neurons in progressive supranuclear palsy.

Authors:  R M Zweig; P J Whitehouse; M F Casanova; L C Walker; W R Jankel; D L Price
Journal:  Ann Neurol       Date:  1987-07       Impact factor: 10.422

10.  Second consensus statement on the diagnosis of multiple system atrophy.

Authors:  S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

View more
  8 in total

1.  Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.

Authors:  Jingjie Ge; Jianjun Wu; Shichun Peng; Ping Wu; Jian Wang; Huiwei Zhang; Yihui Guan; David Eidelberg; Chuantao Zuo; Yilong Ma
Journal:  Hum Brain Mapp       Date:  2018-03-13       Impact factor: 5.038

Review 2.  Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies.

Authors:  Maria Stamelou; Gesine Respondek; Nikolaos Giagkou; Jennifer L Whitwell; Gabor G Kovacs; Günter U Höglinger
Journal:  Nat Rev Neurol       Date:  2021-08-23       Impact factor: 42.937

Review 3.  Accumulation of Tau Protein, Metabolism and Perfusion-Application and Efficacy of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) Imaging in the Examination of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS).

Authors:  Piotr Alster; Natalia Katarzyna Madetko; Dariusz Mariusz Koziorowski; Leszek Królicki; Sławomir Budrewicz; Andrzej Friedman
Journal:  Front Neurol       Date:  2019-02-14       Impact factor: 4.003

4.  Brain Functional and Structural Signatures in Parkinson's Disease.

Authors:  Chunhua Liu; Jiehui Jiang; Hucheng Zhou; Huiwei Zhang; Min Wang; Juanjuan Jiang; Ping Wu; Jingjie Ge; Jian Wang; Yilong Ma; Chuantao Zuo
Journal:  Front Aging Neurosci       Date:  2020-05-26       Impact factor: 5.750

Review 5.  Neuroimaging evaluation of deep brain stimulation in the treatment of representative neurodegenerative and neuropsychiatric disorders.

Authors:  Shichun Peng; Vijay Dhawan; David Eidelberg; Yilong Ma
Journal:  Bioelectron Med       Date:  2021-03-30

6.  A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism.

Authors:  Paraskevi-Evita Papathoma; Ioanna Markaki; Chris Tang; Magnus Lilja Lindström; Irina Savitcheva; David Eidelberg; Per Svenningsson
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379

7.  EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3.

Authors:  Eric Guedj; Andrea Varrone; Ronald Boellaard; Nathalie L Albert; Henryk Barthel; Bart van Berckel; Matthias Brendel; Diego Cecchin; Ozgul Ekmekcioglu; Valentina Garibotto; Adriaan A Lammertsma; Ian Law; Iván Peñuelas; Franck Semah; Tatjana Traub-Weidinger; Elsmarieke van de Giessen; Donatienne Van Weehaeghe; Silvia Morbelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12-09       Impact factor: 10.057

8.  Reproducible metabolic topographies associated with multiple system atrophy: Network and regional analyses in Chinese and American patient cohorts.

Authors:  Bo Shen; Sidi Wei; Jingjie Ge; Shichun Peng; Fengtao Liu; Ling Li; Sisi Guo; Ping Wu; Chuantao Zuo; David Eidelberg; Jian Wang; Yilong Ma
Journal:  Neuroimage Clin       Date:  2020-09-09       Impact factor: 4.881

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.